Atreca Inc (BCEL)
0.092
0.00 (0.00%)
USD |
OTCM |
May 17, 15:59
Atreca Total Liabilities (Quarterly): 15.58M for Sept. 30, 2023
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2023 | 15.58M |
| June 30, 2023 | 70.40M |
| March 31, 2023 | 73.46M |
| December 31, 2022 | 76.62M |
| September 30, 2022 | 75.82M |
| June 30, 2022 | 75.63M |
| March 31, 2022 | 75.91M |
| December 31, 2021 | 45.13M |
| September 30, 2021 | 44.83M |
| June 30, 2021 | 42.24M |
| Date | Value |
|---|---|
| March 31, 2021 | 40.40M |
| December 31, 2020 | 30.01M |
| September 30, 2020 | 13.91M |
| June 30, 2020 | 10.43M |
| March 31, 2020 | 8.834M |
| December 31, 2019 | 8.763M |
| September 30, 2019 | 7.723M |
| June 30, 2019 | 8.498M |
| March 31, 2019 | 4.823M |
| December 31, 2018 | 214.72M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
7.723M
Minimum
Sep 2019
76.62M
Maximum
Dec 2022
40.23M
Average
41.32M
Median
Total Liabilities (Quarterly) Benchmarks
| Catalent Inc | 6.268B |
| NovaBay Pharmaceuticals Inc | 5.197M |
| Palatin Technologies Inc | 9.827M |
| iBio Inc | 24.82M |
| Theriva Biologics Inc | 14.61M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 26.34M |
| Shareholders Equity (Quarterly) | 10.76M |